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Abstract
Information on the replication of viral haemorrhagic fever viruses is not readily available and has never been
analysed in a comparative approach. Here, we compared the cell culture growth characteristics of haemorrhagic
fever viruses (HFV), of the Arenaviridae, Filoviridae, Bunyaviridae, and Flavivridae virus families by performing
quantitative analysis of cell culture supernatants by (i) electron microscopy for the quantification of virus particles,
(ii) quantitative real time PCR for the quantification of genomes, and (iii) determination of focus forming units by
coating fluorescent antibodies to infected cell monolayers for the quantification of virus infectivity.
The comparative analysis revealed that filovirus and RVFV replication results in a surplus of genomes but varying
degrees of packaging efficiency and infectious particles. More efficient replication and packaging was observed for
Lassa virus, and Dengue virus resulting in a better yield of infectious particles while, YFV turned out to be most
efficient with only 4 particles inducing one FFU. For Crimean-Congo haemorrhagic fever virus (CCHFV) a surplus of
empty shells was observed with only one in 24 particles equipped with a genome. The complete particles turned
out to be extraordinarily infectious.
Background
Viral haemorrhagic fevers (VHF) are caused by various
haemorrhagic fever viruses (HFV), of the Arenaviridae,
Filoviridae, Bunyaviridae, and Flavivridae virus families.
Only few laboratories specialize in the research on these
agents. Basic virological information on these viruses is
scant and described exclusively in the frame of case
reports and pathological animal models. Although some
progress has been achieved concerning the interaction
of these viruses with mechanisms of innate immunity
[1-9] and nitrite oxide pathways (CCHFV) [7] concise
information on their basic virological characteristics is
limited. This type of data however is important for bio-
safety risk assessment purposes. Here, we present a
comparative analysis of quantities of HFV in cell culture
determined by electron microscopic counting, quantita-
tive real time RT-PCR and focus forming units, which
reveal some features of the replication of these viruses
that have not been described before.
Methods
Virus propagation
Viral stocks were prepared from Lassa virus (LASV)
strain Josiah, Ebola Zaire virus (EBOVZ) strain Mayinga,
Ebola Sudan virus (EBOSV) strains Maridi and Boniface,
Marburg virus (MARV) strains Ravn, Ozolin and
Musoke, Crimean Congo Haemorrhagic fever virus
(CCHFV) strain IbAr 10200, Rift Valley fever virus
(RVFV) strain ZH 548, Dengue 1 virus (DENV 1) strain
293, Yellow fever virus (YFV) strain Asibi. Confluent
Vero cells (ATCC CCL-81) were inoculated with the
respective virus and grown between 1 and 10 days in
minimal essential medium (MEM) supplemented with
penicillin/streptomycin solution, hepes and 2% heat
inactivated foetal calf serum (all Gibco®BRL, Invitrogen,
Life Technologies, Paisley, U.K.), at 37°C. The superna-
tants with progeny virus were collected and stored at
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-80°C until use. All handling of live virus was carried
out in biosafety (BSL) level 3 or 4 facilities.
Electron microscopy
The electron microscopy studies were performed using a
Philips CM100 electron microscope (Eindhoven, The
Netherlands) as previously described [10]. The viral
supernatants were fixed in 2.5% glutaraldehyde (ratio
1:1) for a minimum of 1 hour in BSL3/4 laboratory,
before decontamination of the tubes and transfer
to BSL2 laboratory following safety instructions. After
fixation, virus particles were pelleted on carbon/For-
mvar-coated 400-mesh copper grids (GilderGrids, Lin-
colnshire, England). Briefly, 150 μl of virus suspension
was centrifuged for 10 min in an Eppendorf 5417C cen-
trifuge (Hamburg, Germany) with a swing-out rotor at a
maximum force of 12,000 × g. The grids were placed on
the flat bottom of the outer container of Sarstedt
microvette CB 300 tubes (Nümbrecht- Rommelsdorf,
Germany). Ten grid squares were counted in each case.
One particle per square equals a concentration of 1.5 ×
105 particles per ml. Grids were stained by 2% tungsto-
phosphoric acid (Merck, Darmstadt, Germany) at pH 6.
Determination of focus-forming units (FFU)
The viruses were titrated 10-fold from 1:10 to 1: 1010 in
MEM and 100 μl of each dilution was transferred to
confluent Vero cells in 96 well tissue culture plates, fol-
lowed by incubation for 24-48 hours at 37°C and 5%
CO2.
Subsequently the supernatants were removed, and the
infected cells were washed 3 times with PBS, before fixa-
tion by cold acetone (80%) in distilled water for 60 min-
utes at -20°C. After fixation, fluorescent focus-forming
assays were performed by incubation of specific antibo-
dies on the infected cells for 30 minutes at 37°C,
followed by incubation with secondary fluorescein-con-
jugated antibodies for additionally 30 minutes at 37°C
(table 1). End point titres (FFU) were set at the last dilu-
tion giving unequivocal fluorescence.
Quantitative real time PCR
RNA was isolated in a BSL3/4 laboratory from the viral
stocks by treatment with TRIZOL Reagent (ratio 1+3)
(Invitrogen) for a minimum of 5 minutes, before decon-
tamination of the tubes and transport to a BSL2 labora-
tory following the safety instructions. Quantitative real
time RT-PCR (qPCR) was performed using published
primers and probes and RNA standards for RVFV, YFV,
EBOZV, EBOSV, MARV and DENV [11-15] and pri-
mers and probes in table 2 for CCHFV and LASV.
CCHFV primers were designed in reference to
sequences U39455, AF467768, NC_005300, of African
CCHFV isolates, the LASV primers were designed
in reference to sequences J04324, AF333969 and
AF246121. Quantitative RNA standards for CCHFV,
LASV were transcribed from the M-segment (CCHFV),
the nucleoprotein gene (LASV) and the 3’ NTR region
(DENV) ligated into pCRII, and evaluated as previously
described [13]. qPCR was performed using the Quanti-
Tect Probe RT-PCR Kit (Qiagen, Hilden Germany) on
the Light Cycler 2.0 (Roche, Mannheim, Germany), and
the following temperature protocol: RT 50°C for 5 min,
activation at
95°C for 15 min, amplification for 45 cycles at 95°C for
5 sec and 60°C for 15 sec. For CCHFV the same proto-
col with a touchdown in two degree steps from 70°C to
64°C for 3 cycles each and 33 cycles at 62°C was used.
Results
Real time PCR
The new qPCR assays for the CCHFV 10200 M-seg-
ment, for LASV Josiah-N and DENV 3’NTR showed an
analytical sensitivity of 100, 10 and 100 detected RNA
molecules and efficiencies (E = 10-1/slope-1) of 0.9, 1.3
and 1.5 respectively.
Table 1 Description of antibodies used for determination of FFU
Virus Primary antibodies Secondary antibodies
LASV Mouse serum Anti-Lassa virus (NP), (in-house) FITC-conjugated Rabbit Anti-Mouse Immunoglobulins, (DAKO
Cytomation, Denmark)
EBOZV/
EBOSV
Mouse serum Anti-Ebola virus (NP), (in-house) FITC-conjugated Goat Anti-Mouse IgG, (Jackson ImmunoResearch,
Baltimore, USA)
MARV Human patient serum FITC-conjugated Goat Anti-Human IgG (FC specific), (Sigma-Aldrich
Ltd., UK)
CCHFV Rabbit serum Anti-CCHFV (NP), (in-house) FITC-conjugated Goat Anti-Rabbit IgG (H+L), (Jackson
ImmunoResearch, Baltimore, USA)
RVFV Mouse polyclonal antibodies (provided by Michele Bouloy,
Pasteur Institute, Paris).
FITC-conjugated Rabbit Anti-Mouse Immunoglobulins, (DAKO
Cytomation, Denmark)
DENV 1 Mouse monoclonal to Dengue Virus E glycoprotein, (Abcam,
Cambridge, UK)
FITC-conjugated Goat Anti-Mouse IgG, (Jackson ImmunoResearch,
Baltimore, USA)
YFV Mouse Monoclonal to Yellow Fever Virus, (Abcam, Cambridge,
UK)
FITC-conjugated Goat Anti-Mouse IgG, (Jackson ImmunoResearch,
Baltimore, USA)
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Determination of virus quantities
The virus titers were determined from 1 ml virus tissue
culture supernatant by (i) electron microscopy (EM),
(ii) quantitative real time PCR (qPCR) of RNA genomes
extracted from the culture supernatant and (iii) determina-
tion of focus forming units (FFU) on cell monolayers
infected with the supernatant using fluorescent antibodies.
The viral genome counts were generally from 1 to 2
orders of magnitude (log10-steps) higher than the particle
counts (table 3, column 4). The FFU counts showed much
greater differences being up to 5 log10-steps lower than
the particle counts (table 3, column 5) and 1-6 log10-steps
lower than genome counts (table 3, column 6).
The EBOZV and EBOSV strains showed a genome
count +2 log10-step higher than the particle count, but
much lower FFU counts differing by -3 to -5 log10-steps
from the particle count. MARV strains Ravn and Ozolin
showed almost equal particle and genome counts, whereas
MARV Musoke showed a -1 log10-step reduction in the
genome count compared to the particle count. As for
EBOZV and EBOSV, the FFU counts of the MARV strains
were -3 to -4 log10-steps lower than the particle counts.
The difference between genome and particle count for
LASV, RVFV, and DENV was between +1 to +2 log10-
steps. The FFU reduction from the particle count for
these viruses ranged between -2 and -3 log10-steps.
YFV was the only virus were particle and FFU count
equalled each other topped only by a +1 log10-step gen-
ome count and the lowest difference (-1 log10-step) of
the FFU count to the genome count.
Apart from YFV, CCHFV showed the lowest level of dif-
ference between FFU and particle count (-1 log10-step). In
comparison to YFV a +1 log10-step increased genome
count over the particle therefore leads to a -2 log10-step
reduction of the FFU count to the genome count.
To interpret the data obtained, ratios were formed
between all three quantitative data sets. The observed
ratios of particles/FFU (table 4, column 1) point out
that for LASV, CCHFV and YFV only few particles (1-
102) are associated with one FFU, whereas for all other
viruses much higher amounts (103-105) were counted
(103 for EBOZV, MARV Ravn, MARV Ozolin, RVFV
and DENV 1, 104 for EBOSV Boniface, MARV Musoke
and 105 for EBOSV Maridi).
The ratios of genomes per particle and its reciprocal
(table 4, column 2 and 3) indicate that most viruses
appear to be overproducing genomes only packaging a
fraction of genomes into shells to create complete parti-
cles. EBOZV, EBOSV, and RVFV seem to produce a
surplus in the range of 74 - 336 genomes in relation to
the shells produced while this surplus is of reduced
magnitude for LASV, DENV and YFV (about 15-20).
MARV appears to be efficiently packaging every 3rd -
5th genome into a particle (table 4, column 3) achieving
this by a slight overproduction of shells. The CCHFV
machinery produces 23 empty shells for 1 particle
packed with a genome. The packed genomes however
are highly infectious as indicated by the value of 1 for
the ratio of FFU/genomes (table 4 column 4).
Discussion
The comparative quantitative analysis of virus titers in
cell culture using three independent methods revealed
some insight into the packaging efficiency of the viruses
Table 2 Primers and probes
Virus Oligomer Sequence 5`to 3’
CCHFV CCFM FP TCACCTTAGAGGAGGACACTGAAGG
CCFM RP CTCTTTTGAAAGAAAGTGTCATCACAATC
CCHF M LNA 6FAM - TGGTGTAAGAGAAATC - BBQ
LASV LAS FP YAACTCTGCATTYTTCACATCCC
LAS RP TGGGMAACCTAAGYTCACAGCA
LAS P 6FAM - ACCACTCCATCTCTCCCAGCC - TMR
LNA Nucleotides in bold, IUB code used Y for C/T, M for A/C, dyes and
quenchers used: 6FAM =, 6-Carboxyfluorescein BBQ = Black Berry Quencher,
TMR = Tetramethylrhodamin.
Table 3 Quantitative detemination of virus titers
Virus EM particles/ml PCR genomes/ml Infectivity FFU/ml log10 difference
PCR to EM
log10 difference
FFU to EM
log10 difference
FFU to PCR
EBOZV Mayinga 2.5 × 108 8.3 × 1010 ± 3.2 × 109 1.0 × 105 +2 -3 -5
EBOSV Maridi 7.5 × 108 8.6 × 1010 ± 5.4 × 109 1.0 × 103 +2 -5 -7
EBOSV Boniface 8.0 × 108 5.9 × 1010 ± 3.4 × 109 1.0 × 104 +2 -4 -6
MARV Ravn 4.0 × 108 1.3 × 108 ± 1.8 × 106 1.0 × 105 0 -3 -3
MARV Ozolin 5.0 × 109 1.6 × 109 ± 1,1 × 108 1.0 × 106 0 -3 -3
MARV Musoke 3.0 × 109 5.8 × 108 ± 2.7 × 107 1.0 × 105 -1 -4 -3
LASV Josiah 1.0 × 106 2.2 × 107 ± 4.7 × 106 1.0 × 104 +1 -2 -3
RVFV ZH548 2.5 × 109 2.9 × 1011 ± 4.3 × 109 1.0 × 106 +2 -3 -5
DENV-1 231 3.0 × 109 4.6 × 1010 ± 4.3 × 109 1.0 × 106 +1 -3 -4
YFV Asibi 4.0 × 108 8.2 × 109 ± 1.7 × 108 1.0 × 108 +1 0 -1
CCHFV 10200 2.5 × 107 1.0 × 106 ± 6.1 × 105 1.0 × 106 +1 -1 -2
EM: calculated from 10 grid squares, qPCR: average and standard deviation of triplicate qPCR results (8 qPCR results for CCHFV), FFU: mean of three titrations.
Weidmann et al. Virology Journal 2011, 8:81
http://www.virologyj.com/content/8/1/81
Page 3 of 6
analysed. The viral RNA genomes were quantified from
cell culture supernatants, which most certainly con-
tained free RNA genomes from lysed cells for all of the
viruses except for CCHFV, which does not induce a
cytopathic effect in Vero cells. Nevertheless, there are
some prominent differences in the magnitude of gen-
omes and particle production observed.
In the group of the filoviruses there seems to be a
clear separation between the growth characteristics of
EBOZV and EBOSV on the one hand, and MARV
strains on the other hand. While Ebola viruses appear to
produce a 2 log10-step surplus of genomes over the par-
ticles detectable in EM, the particle and genome values
for MARV are almost at the same level. Surprisingly in
spite of the production surplus of 108-109 particles both
filovirus types seem to produce comparatively few infec-
tious particles with FFU counts down by 3 to 4 log10-
steps from the amount of particles (and genomes) for
MARV and 4 to 5 log10-steps down for EBOZV and
EBOSV. Due to the overproduction the resulting
amounts of FFU are still veritable but it appears that
efficient genome packing by MARV (1 genome in 3-5
particles) by producing more shells than genomes does
not lead to a high rate of infectious particles, as about
1000 particles are needed to induce one FFU. For
EBOZV and EBOSV a 100-fold overproduction of gen-
omes only yields an even lower amount of infectious
particles, as 103-105 are needed to induce one FFU. It
seems fair to say that at least as observed in cell culture
particle and genome production seem to run out of
sync resulting in a proportionally low amount of infec-
tious particles.
In experimental animal models for EBOZV doses as
low as one plaque-forming unit suffice to cause infec-
tion [16]. The amount of particles recorded for one FFU
indicate that although particle production is not very
efficient indeed the overall high amount of particles pre-
sent in one plaque guarantee infection.
Cellular growth of RVFV seems comparable to that of
EBOZV Mayinga with very high yields of particles (108)
and genomes (1011) leading to 1 genome in 119 being
packed into a particle of which 103 are needed to induce
one FFU. In recent experiments sheep were successfully
inoculated with RVFV at a dose of 1 × 105 TCID50 [17].
TCID50 and FFU are not easy to relate but it seems that
there is much scope to determine a much lower infec-
tious dose of RVFV.
The difference between particle count and genome
count for LASV is low and reflected in a genome to par-
ticle ratio of 22 indicating a good correlation between
virus particles and genomes produced. The efficiency of
the virus particles and their infectiousness (100/FFU)
observed in cell culture is reflected by the fact that ani-
mal models can be highly susceptible to lethal infection
as for example to 2 PFU for inbred strain 13 guinea pig
[18]. A similar efficiency of the LASV particles was
observed in LASV virus-infected marmoset tissues,
which contained significant amounts of viral RNA com-
parable with levels of viremia (measured in PFU) [19].
The best yield of correctly packaged particles is
obtained by YFV and CCHFV indicating efficient syn-
chronisation of shell and genome production (table 4,
column 4) by these viruses.
DENV packs genomes even more efficiently than
LASV and YFV (1 in 15 as compared to 1 in 20). The
resulting DENV particles are however much less infec-
tious than the YFV particles and about 103 are needed
to induce one FFU.
YFV presents itself as the most efficient packer, lead-
ing to a very high ratio of infectious particles since it is
the only virus for which particle count and FFU count
are the same. From the ratios formed it appears that a
slight overproduction of genomes (1 log10 - steps up
from the particle count) is conducive to a genome
packaging ratio of 1 in 21 of which only 4 are needed to
induce one FFU. Rhesus monkeys have been successfully
infected with 7 × 102 plaque forming units (PFU) deter-
mined on vero E6 cells [20]. Our results show that the
YFV particles indeed are highly infectious and that the
infectious dose needed for animal models might be even
below the dose used.
CCHFV does not induce a CPE in vero cells and
therefore additional viral RNA genomes released by cell
lysis do not contribute to the genome count. Therefore
the assembly modalities of the infectious CCHFV parti-
cles appear reverse to those of the other viruses, as only
every 24th particle will actually contain a genome lead-
ing to a surplus of empty shells. The correctly
assembled particles however are highly infectious as
each of them induces a FFU. In the EM analysis
Table 4 Selected ratios of quantitative titer results
Virus particles/
FFU
genomes/
particle
particles/
genome
genome/
FFU
EBOZV
Mayinga
2.5 × 103 336 0.00 8.3 × 105
EBOSV Maridi 7.5 × 105 115 0.01 8.6 × 107
EBOSV
Boniface
8.0 × 104 74 0.01 5.9 × 106
MARV Ravn 4.0 × 103 0.3 3.08 1.3 × 103
MARV Ozolin 5.0 × 103 0.3 2.98 1.6 × 103
MARV Musoke 3.0 × 104 0.2 5.10 5.8 × 103
LASV Josiah 100 22 0.05 2.2 × 103
RVFV ZH548 2.5 × 103 119 0.01 2.9 × 107
DENV 1 231 3.0 × 103 15 0.06 4.6 × 104
YFV Asibi 4 21 0.05 83
CCHFV IbAR
10200
25 0.04 24 1
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malformed CCHFV particles were noticed (see Figure 1).
Defective interfering particles (DIP) have been described
for almost all types of DNA and RNA viruses. DIP have
an influence on the viable virus yields (measured in
PFU) in cell culture. Particular ratios of DIP to viable
virus are conducive to good or bad yields of progeny
virus. The mathematical models for this relationship
have been extended recently [21]. The extraordinary
infectious CCHFV particles (1 genome/FFU) indicate
that the malformed CCHFV particles observed might be
DIP driving this type of yield.
A recent study showed that 10 FFU sufficed to kill
IFNAR -/- mice lacking the IFN receptor. These mice do
not develop an innate immune response and therefore
develop acute disease which makes them a good model
for CCHFV infection and disease [22]. These results
confirm the extraordinary infectiousness of the CCHFV
particles observed in our study.
Conclusion
The analysed quantitative virus titers indicate that YFV
and CCHFV virus are the most efficient in producing
infectious particles. These viruses manage to synchro-
nise genome and particle production in an optimal fash-
ion as opposed for example to the filoviruses with an
apparent overflowing and inefficient production of gen-
omes and particles. YFV and CCHFV represent the opti-
mal synchronisation of the replication strategies
observed i.e. overproduction of genomes and overpro-
duction of shells respectively.
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